AC Immune SA (ACIU)
2.35
+0.05
(+2.17%)
USD |
NASDAQ |
Jun 02, 16:00
2.34
-0.01
(-0.43%)
After-Hours: 20:00
AC Immune Net Income (TTM): -72.74M for March 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -72.74M |
| December 31, 2022 | -74.24M |
| September 30, 2022 | -77.84M |
| June 30, 2022 | -81.18M |
| March 31, 2022 | -81.76M |
| December 31, 2021 | -79.86M |
| September 30, 2021 | -78.35M |
| June 30, 2021 | -81.67M |
| March 31, 2021 | -77.06M |
| December 31, 2020 | -66.51M |
| September 30, 2020 | -64.58M |
| June 30, 2020 | -25.44M |
| March 31, 2020 | -25.96M |
| December 31, 2019 | 45.79M |
| September 30, 2019 | 50.70M |
| Date | Value |
|---|---|
| June 30, 2019 | 18.48M |
| March 31, 2019 | 24.02M |
| December 31, 2018 | -52.03M |
| September 30, 2018 | -33.08M |
| June 30, 2018 | -28.48M |
| March 31, 2018 | -29.68M |
| December 31, 2017 | -26.85M |
| September 30, 2017 | -35.83M |
| June 30, 2017 | -36.02M |
| March 31, 2017 | -10.18M |
| December 31, 2016 | -6.978M |
| September 30, 2016 | -7.848M |
| June 30, 2016 | 22.31M |
| March 31, 2016 | 18.10M |
| December 31, 2015 | 21.20M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-81.76M
Minimum
Mar 2022
50.70M
Maximum
Sep 2019
-43.09M
Average
-65.54M
Median
Net Income (TTM) Benchmarks
| Roche Holding AG | 12.88B |
| CRISPR Therapeutics AG | -524.02M |
| Addex Therapeutics Ltd | -18.13M |
| NLS Pharmaceutics Ltd | -16.50M |
| VectivBio Holding AG | -93.74M |